Plasma Exchange Downregulates Activated Monocytes and Restores Regulatory T Cells in Kawasaki Disease

Infliximab regulates monocytes and regulatory T cells in Kawasaki disease

(2018) Keiichi Koizumi et al.   PEDIATRICS INTERNATIONAL

Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities

(2017) Takeshi Moriguchi et al.   JOURNAL OF ARTIFICIAL ORGANS

Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease

(2015) M. M.-H. Guo et al.   ALLERGY

Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange

(2014) Takuya Fujimaru et al.   CYTOKINE

Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease

(2014) Manoochehr Rasouli et al.   IMMUNOLOGY LETTERS

The mechanisms of action of plasma exchange

(2013) Hollie M. Reeves et al.   BRITISH JOURNAL OF HAEMATOLOGY

Lack of CD4+CD25+FOXP3+ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease

(2013) Yu Hirabayashi et al.   EUROPEAN JOURNAL OF PEDIATRICS

Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis

(2012) E. Choy   RHEUMATOLOGY

Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease

(2011) Tatsunori Hokosaki et al.   PEDIATRICS INTERNATIONAL

The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease

(2010) S. Jia et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A Report of Two Cases of Kawasaki Disease Treated With Plasma Exchange

(2008) Tomonori Harada et al.   THERAPEUTIC APHERESIS AND DIALYSIS